Enliven to Present Clinical Data at SOHO 2026 Meeting
SAN FRANCISCO, California, Sept. 2, 2026 Enliven Therapeutics announced plans to present new clinical and preclinical data from its...
Ebola outbreak
Advertisement
UCB Agreement Targets Medicine Costs and U.S. Manufacturing
BRUSSELS, Belgium and ATLANTA, Georgia, Aug. 31, 2026 UCB has reached an agreement with the U.S. government aimed at...
TTX-MC138 Shows Survival Benefit in Breast Cancer
BOSTON, Aug. 31, 2026 TransCode Therapeutics announced the publication of new peer-reviewed research reporting a survival benefit for TTX-MC138...
RedHill Advances Opaganib for Ebola Outbreak Response
Raleigh, North Carolina, August 31, 2026 RedHill Biopharma Ltd. announced an update on the emergency development of opaganib as...
GHIT Fund Accelerates Portable Ebola Diagnostic Innovation
TOKYO, Japan, July 23, 2026 The Global Health Innovative Technology (GHIT) Fund has announced an investment of approximately JPY...
Advertisements
QIAGEN Launches Bundibugyo Ebola Research Assays to Support Outbreak Surveillance
VENLO, Netherlands & GERMANTOWN, Md., May 28, 2026 QIAGEN announced the availability of two custom-designed research-use-only (RUO) QIAcuity digital...
Regeneron’s Ebola Antibody Prioritized by WHO for Bundibugyo Outbreak Research
TARRYTOWN, N.Y. | May 28, 2026 Regeneron Pharmaceuticals announced that maftivimab, the lead neutralizing antibody within its FDA-approved Ebola...
Soligenix Advances Bundibugyo Ebola Vaccine Platform
PRINCETON, New Jersey, May 26, 2026 Soligenix, Inc. has announced that its proprietary ThermoVax® vaccine platform may provide a...
Advertisement
